Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Frankfurt - Delayed Quote EUR

Adverum Biotechnologies, Inc. (AVU0.F)

2.5800
+0.1200
+(4.88%)
As of 8:54:38 AM GMT+2. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
1,000
1,000
3,600
--
7,500
Operating Expense
140,159
140,159
132,542
157,135
153,622
Operating Income
-139,159
-139,159
-128,942
-157,135
-146,122
Other Income Expense
8,232
8,232
5,748
2,673
582
Pretax Income
-130,927
-130,927
-123,194
-154,462
-145,540
Tax Provision
--
--
-1,078
74
--
Net Income Common Stockholders
-130,927
-130,927
-122,116
-154,536
-145,540
Diluted NI Available to Com Stockholders
-130,927
-130,927
-122,116
-154,536
-145,540
Basic EPS
-5.95
-6.62
-12.11
-15.60
-14.80
Diluted EPS
-5.95
-6.62
-12.11
-15.60
-14.80
Basic Average Shares
17,086.6500
19,782
10,082
9,925.1000
9,803.9000
Diluted Average Shares
17,086.6500
19,782
10,082
9,925.1000
9,803.9000
Total Operating Income as Reported
-139,159
-139,159
-128,942
-157,135
-146,122
Total Expenses
140,159
140,159
132,542
157,135
153,622
Net Income from Continuing & Discontinued Operation
-130,927
-130,927
-122,116
-154,536
-145,540
Normalized Income
-130,927
-130,927
-122,116
-154,536
-145,540
EBIT
-139,159
-139,159
-128,942
-157,135
-146,122
EBITDA
-135,506
-135,506
-123,298
-150,607
-141,477
Reconciled Depreciation
3,653
3,653
5,644
6,528
4,645
Net Income from Continuing Operation Net Minority Interest
-130,927
-130,927
-122,116
-154,536
-145,540
Normalized EBITDA
-135,506
-135,506
-123,298
-150,607
-141,477
Tax Rate for Calcs
--
--
0
0.0002
--
12/31/2021 - 8/5/2014

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

1JK.F Apellis Pharmaceuticals, Inc.
14.78
-6.43%
 
1T3.F Syndax Pharmaceuticals, Inc.
11.50
+2.68%
 
F6T.F Fate Therapeutics, Inc.
1.1715
+2.14%
 
SION Sionna Therapeutics, Inc.
12.60
-3.74%
 
THRD Third Harmonic Bio, Inc.
5.14
-0.19%
 
TENX Tenax Therapeutics, Inc.
5.77
+5.68%
 
FULC Fulcrum Therapeutics, Inc.
3.5100
-2.23%
 
KYTX Kyverna Therapeutics, Inc.
2.1400
+0.47%
 
NGNE Neurogene Inc.
15.37
-0.45%
 
SNDX Syndax Pharmaceuticals, Inc.
13.30
+2.31%